Investor relations
Commercialisation of protein-based precision diagnostics through transparent communications with shareholders and investors.
Shareholder Information
The latest share price information for Proteomics International is available on the Australian Stock Exchange website, using the ASX Code: PIQ.
Proteomics International Laboratories Ltd shares can be traded on ASX.
Share Registry
Proteomics International Laboratories Ltd’s share register is maintained by Automic.
Security holders can view their holdings, obtain statements and maintain their personal information via the online portal provided by Automic. You will need your Security Reference Number (SRN) or Holder Identification Number (HIN) – displayed on Issuer Sponsored/CHESS holding statements.
Alternatively, security holders can contact Automic directly using the contact details provided below.
Postal address: GPO Box 5193, Sydney NSW 2000
Telephone: 1300 288 664 (within Australia)
Telephone: +61 2 9698 5414 (outside Australia)
Email: hello@automic.com.au
Stay informed
Receiving your shareholder communications electronically is the best way to stay informed and will help to minimise paper usage. If you have not already, we encourage you to make the switch to paperless communications and provide us with your email address.
You can make a standing election to receive some or all of your shareholder communications in physical or electronic form.
Of course, you will always be able to access and read our Annual Report, Notice of Meeting and other shareholder documents when they are published on our website and the ASX platform.
Review or update your preference
Simply log on to the registry portal and update your ‘Communication Preferences’ under ‘My Details’:
Scientific Publications
Proteomics International's technologies are supported by a growing body of peer-reviewed scientific publications. Explore the clinical and scientific evidence underpinning Promarker®D, Promarker®Eso and Promarker®Endo.
Corporate Information
Issuer Code: PIQ Official Listing
Date: 16 April 2015 GICS Industry Group: Pharmaceuticals, Biotechnology & Life Sciences
Mailing address: Box 3008, Broadway, Nedlands, WA 6009, Australia
Head Office Telephone: +61 8 9389 1992
Email address: enquiries@proteomicsinternational.com